Franklin Biotechnology Discovery Fund Investor Sentiment

FTDZX Fund  USD 135.32  1.16  0.86%   
Slightly above 51% of Franklin Biotechnology's investor base is interested to short. The analysis of overall sentiment of trading Franklin Biotechnology Discovery mutual fund suggests that many investors are impartial at this time. Franklin Biotechnology's investor sentiment overview provides quick insight into current market opportunities from investing in Franklin Biotechnology Discovery. The current market sentiment, together with Franklin Biotechnology's historical and current headlines, can help investors time the market. In addition, many technical investors use Franklin Biotechnology fund news signals to limit their universe of possible portfolio assets and to time the market correctly.
Franklin Biotechnology mutual fund news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Franklin daily returns and investor perception about the current price of Franklin Biotechnology Discovery as well as its diversification or hedging effects on your existing portfolios.
  
over a year ago at news.google.com         
Content is king Digital materials linked to 2.5 times boost to new ... - FiercePharma
Google News at Macroaxis
18 hours ago at seekingalpha.com         
Neurocrine stock gains on depression trial win
seekingalpha News
few days ago at benzinga.com         
Market Analysis Regeneron Pharmaceuticals And Competitors In Biotechnology Industry
benzinga news
six days ago at seekingalpha.com         
Sentia Medical Sciences and Neurocrine Biosciences extend research collaboration
seekingalpha News
over a week ago at medcitynews.com         
Disposition of 12587 shares by Eric Benevich of Neurocrine Biosciences at 81.05 subject to Rule 16b-...
news
over a week ago at finance.yahoo.com         
11 Best Biotech ETFs To Buy
Yahoo News
over two weeks ago at finance.yahoo.com         
Disposition of 272 shares by Ingrid Delaet of Neurocrine Biosciences at 79.02 subject to Rule 16b-3
Yahoo News
over two weeks ago at investors.com         
Disposition of 272 shares by Ingrid Delaet of Neurocrine Biosciences at 79.02 subject to Rule 16b-3
Investors Business Daily at Macroaxis
over three weeks ago at investing.com         
Neurocrine begins Phase 1 trial for treatment of neurological conditions
Investing News at Macroaxis
over a month ago at investors.com         
Stock Rally Keeps Going With Dow, SP 500 At New Highs Micron Soars After Big Surprise
Investors Business Daily at Macroaxis
over a month ago at investing.com         
H.C. Wainwright bullish on Voyager Therapeutics stock, cites CNS focus
Investing News at Macroaxis
over a year ago at finance.yahoo.com         
Antibody Drug Conjugates Global Market Report 2023
Yahoo News
18 hours ago at finance.yahoo.com         
Global Diabetes Drugs Market to Witness an Upsurge in Growth by 2030, Examines DelveInsight Key Comp...
Yahoo News
3 days ago at finance.yahoo.com         
2 Everlasting Big Pharma Stocks to Buy Today and Hold Forever
Yahoo News
few days ago at techradar.com         
The party is over for developers looking for AI freebies Google terminates Gemini API free access wi...
news
few days ago at businesswire.com         
Vertex Announces Advancements of Suzetrigine in Acute and Neuropathic Pain
businesswire News
few days ago at investing.com         
Earnings call Omnicom Group sees growth, raises full-year outlook
Investing News at Macroaxis
six days ago at finance.yahoo.com         
Cystic Fibrosis Market Pipeline Insights Report 2024 Featuring 75 Companies and 80 Pipeline Drugs, I...
Yahoo News
six days ago at finance.yahoo.com         
Vertex Pharmaceuticals Stock Falls Amid Market Uptick What Investors Need to Know
Yahoo News
over a week ago at zacks.com         
Investors Heavily Search Vertex Pharmaceuticals Incorporated Here is What You Need to Know
zacks News
over a week ago at statnews.com         
STAT Pharmalittle Were reading about AstraZeneca CEO pay, alternatives to WuXi and more
news
over a week ago at investorplace.com         
Raymond James Just Raised Its Price Target on Nvidia Stock
sbwire news
over three months ago at reuters.com         
Pfizer forecasts 2024 profit, revenue below Wall Street expectations
reuters
over three months ago at seekingalpha.com         
Pfizer stock slips as 2024 guidance disappoints
seekingalpha News
over three months ago at cnbc.com         
Why investors should only trade a name like Linde on fundamentals
cnbc News
over three months ago at finance.yahoo.com         
Were Interested To See How Seagen Uses Its Cash Hoard To Grow
Yahoo News
over three months ago at businesswire.com         
ADCETRIS Plus Novel Immunotherapy Combination Delivers 100 percent Progression Free Survival at 12 m...
businesswire News
over three months ago at businesswire.com         
ADCETRIS Plus Novel Immunotherapy Combination Delivers 100 percent Progression Free Survival at 12 m...
businesswire News
over three months ago at dragonflycap.com         
5 Trade Ideas for MondayArista, Comerica, Interactive Brokers, Seagen and Teck Resources
news
over three months ago at benzinga.com         
100 Invested In Seagen 20 Years Ago Would Be Worth This Much Today
benzinga news
over three months ago at businesswire.com         
TUKYSA in Combination with Antibody-Drug Conjugate ado-Trastuzumab Emtansine Improves Progression-Fr...
businesswire News
over three months ago at thelincolnianonline.com         
Seagen Inc. Receives 193.00 Average PT from Analysts
news
over six months ago at www.macroaxis.com         
Disposition of 49701 shares by Michael Wortley of Reata Pharmaceuticals subject to Rule 16b-3
Macroaxis News
over six months ago at news.google.com         
Reata Pharmaceuticals, Inc. Is Expected To Breakeven In The Near Future - Yahoo Finance
Google News at Macroaxis
over six months ago at thelincolnianonline.com         
Reata Pharmaceuticals Research Coverage Started at StockNews.com
news
over six months ago at thelincolnianonline.com         
Reata Pharmaceuticals, Inc. Stock Holdings Trimmed by Swiss National Bank
news
over six months ago at thelincolnianonline.com         
StockNews.com Begins Coverage on Reata Pharmaceuticals
news
over six months ago at www.macroaxis.com         
Sale by Michael Wortley of 807 shares of Reata Pharmaceuticals
Macroaxis News
over six months ago at zacks.com         
Alimera Sciences Reports Q2 Loss, Lags Revenue Estimates
zacks News
over six months ago at zacks.com         
Entrada Therapeutics, Inc. Reports Q2 Loss, Misses Revenue Estimates
zacks News
over six months ago at Macroaxis         
Should you quit your Reata Pharmaceuticals (USA Stocks:RETA) holdings?
Macroaxis News
over six months ago at thelincolnianonline.com         
Reata Pharmaceuticals Cut to Neutral at LADENBURG THALMSH SH
news
18 hours ago at finance.yahoo.com         
Kiniksa Pharmaceuticals Reports First Quarter 2024 Financial Results and Recent Portfolio Execution
Yahoo News
few days ago at finance.yahoo.com         
Nykode Therapeutics Initiates Phase 2 Trial of VB10.16 in Second Line HPV16-Positive Cervical Cancer
Yahoo News
few days ago at benzinga.com         
REGENERON ALERT Bragar Eagel Squire, P.C. is Investigating Regeneron Pharmaceuticals, Inc. on Behalf...
benzinga news
few days ago at accesswire.com         
IMPORTANT INVESTOR ALERT The Schall Law Firm Announces it is Investigating Claims Against Regeneron ...
news
few days ago at businesswire.com         
The Law Offices of Frank R. Cruz Announces Investigation of Regeneron Pharmaceuticals, Inc. on Behal...
businesswire News
six days ago at seekingalpha.com         
Regeneron to defend in Eylea pricing lawsuit
seekingalpha News
six days ago at finance.yahoo.com         
Disposition of tradable shares by Arthur Ryan of Regeneron Pharmaceuticals at 986.58 subject to Rule...
Yahoo News
over a week ago at finance.yahoo.com         
Regeneron to defend US Justice Departments complaint on drug-pricing manipulation
Yahoo News
over a week ago at finance.yahoo.com         
Regeneron to defend US Justice Departments complaint on drug-pricing manipulation
Yahoo News
over a week ago at investing.com         
Jefferies raises Regeneron shares target on limited impact view
Investing News at Macroaxis
18 hours ago at finance.yahoo.com         
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635
Yahoo News
few days ago at investing.com         
PTC Therapeutics CEO sells shares worth over 19k
Investing News at Macroaxis
few days ago at zacks.com         
PTC Therapeutics Expected to Beat Earnings Estimates Can the Stock Move Higher?
zacks News
over a week ago at news.google.com         
PTC Therapeutics Stock Rating Reaffirmed by Cantor Fitzgerald - MarketBeat
Google News at Macroaxis
over two weeks ago at simplywall.st         
Shareholders in PTC Therapeutics have lost 44, as stock drops 5.5 percent this past week
Simply Wall St News at Macroaxis
over two weeks ago at www.macroaxis.com         
Disposition of 526 shares by Golden Lee Scott of PTC Therapeutics at 28.37 subject to Rule 16b-3
Macroaxis News
over three weeks ago at news.google.com         
PTC Therapeutics, Inc. Receives 33.53 Consensus PT from Brokerages - MarketBeat
Google News at Macroaxis
over three weeks ago at accesswire.com         
PTC Therapeutics, Inc. Investigated Regarding Potential Securities Law Violations - Contact Levi Kor...
news
over a month ago at accesswire.com         
PTCT ACTIVE INVESTIGATION Contact Levi Korsinsky if you lost money on your PTC Therapeutics, Inc. in...
news
over a month ago at accesswire.com         
ATTENTION PTCT SHAREHOLDERS Investors who lost money on PTC Therapeutics, Inc. are urged to contact ...
news
a day ago at finance.yahoo.com         
How Should You Play Merck Stock Ahead of Q1 Earnings?
Yahoo News
few days ago at finance.yahoo.com         
12 Most Shorted Stocks in 2024
Yahoo News
six days ago at accesswire.com         
Levi Korsinsky, LLP Notifies Shareholders of Novavax, Inc. an Upcoming Claims Deadline in a Class Ac...
news
over a week ago at finance.yahoo.com         
UPDATE 1-Hedge fund Shah Capital urges Novavax board shake-up, FT says
Yahoo News
over a week ago at seekingalpha.com         
Shah Capital calls for board shake-up at Novavax
seekingalpha News
over a week ago at finance.yahoo.com         
Better Buy Bluebird Bio Vs. Novavax
Yahoo News
over a week ago at finance.yahoo.com         
JJ to Begin Pharma Q1 Earnings Season Whats in Store?
Yahoo News
over a week ago at accesswire.com         
Levi Korsinsky, LLP Notifies Shareholders of Novavax, Inc. an Upcoming Claims Deadline in a Class Ac...
news
over a week ago at aol.com         
On eve of Japanese prime ministers visit to North Carolina, Fujifilm announces more jobs there
news
over a week ago at news.google.com         
Novavax stock spikes 29 percent after company snags 350 million from Canada for unused Covid shots -...
Google News at Macroaxis
over two months ago at thelincolnianonline.com         
Mirati Therapeutics Now Covered by Analysts at StockNews.com
news
over two months ago at finance.yahoo.com         
Billionaire Joe Lewis Pleads Guilty in Insider Trading Case
Yahoo News
over two months ago at smh.com.au         
Billionaire pleads guilty in insider trading case with a link to an Australian giant
news
over three months ago at streetinsider.com         
Frances Sanofi to buy U.S. drugs project INBRX-101 for about 2.2 billion
Street Insider News
over three months ago at streetinsider.com         
Frances Sanofi to buy U.S. drugs project INBRX-101 for about 2.2 billion
Street Insider News
over three months ago at streetinsider.com         
Frances Sanofi to buy U.S. drugs project INBRX-101 for about 2.2 billion
Street Insider News
over three months ago at streetinsider.com         
Frances Sanofi to buy U.S. drugs project INBRX-101 for about 2.2 billion
Street Insider News
over three months ago at aol.com         
Frances Sanofi to buy U.S. drugs project INBRX-101 for about 2.2 billion
news
over three months ago at seekingalpha.com         
Mirati Therapeutics stock ticks higher amid Nasdaq delisting for sale to Bristol-Myers
seekingalpha News
over three months ago at thelincolnianonline.com         
Brokerages Set Mirati Therapeutics, Inc. PT at 60.00
news
18 hours ago at investorplace.com         
Medical AI Could Be Your Ticket to Riches 3 Stocks to Buy
sbwire news
2 days ago at finance.yahoo.com         
Insiders At Moderna Sold US3.3m In Stock, Alluding To Potential Weakness
Yahoo News
few days ago at zacks.com         
Moderna Stock Moves -0.58 percent What You Should Know
zacks News
few days ago at finance.yahoo.com         
TriLink BioTechnologies Announces New San Diego Facility for Late Phase mRNA Drug Substance Producti...
Yahoo News
few days ago at benzinga.com         
Moderna Options Trading A Deep Dive into Market Sentiment
benzinga news
few days ago at zacks.com         
Moderna Stock Moves -0.34 percent What You Should Know
zacks News
six days ago at newswire.com         
AmplifyBio and RNAV8 Bio Announce Strategic Partnership to Support mRNA Therapeutic Developers from ...
news
six days ago at investing.com         
Moderna president sells 1.58m in company stock
Investing News at Macroaxis
over a week ago at bizjournals.com         
Disposition of 15000 shares by Hoge Stephen of Moderna at 105.02 subject to Rule 16b-3
bizjournals News
over a week ago at zerohedge.com         
CDC Study Doesnt Debunk Link Between COVID-19 Vaccines Sudden-Deaths
news
18 hours ago at accesswire.com         
Jazz Pharmaceuticals Employees Wear Purple To Support Epilepsy Awareness and Community
news
a day ago at 48hills.org         
Screen Grabs SFFILM Fest unleashes Dizzy Gillespie, Chiwetel Ejiofor, June Squibb
news
few days ago at scitechdaily.com         
High Hopes How d-Limonene Curbs the Anxiety of THC
news
six days ago at finance.yahoo.com         
Acute Lymphocytic Leukemia Pipeline Landscape Report 2024 Comprehensive Insights About 250 Companies...
Yahoo News
over a week ago at finance.yahoo.com         
Disposition of 3204 shares by Renee Gala of Jazz Pharmaceuticals at 119.13 subject to Rule 16b-3
Yahoo News
over a week ago at finance.yahoo.com         
Alkermes ALKS 2680 Betters Wakefulness in Phase Ib Study
Yahoo News
over a week ago at finance.yahoo.com         
Jazz honoured at Nova Scotia Professional HR Awards
Yahoo News
over two weeks ago at aol.com         
Mann leads 8 Clippers in double figures in 131-102 rout of Jazz. Utah loses its 11th in a row
news
over two weeks ago at zacks.com         
Pharma Stock Roundup AZN Voydeya Gets FDA Nod, MRK KRAS Inhibitor Enters Phase III
zacks News
over two weeks ago at finance.yahoo.com         
Frank Lampheres New Album Brand of Blue-Collar Jazz Promises Years of Listening Enjoyment, Especiall...
Yahoo News
a day ago at www.macroaxis.com         
Disposition of 11248 shares by Igor Bilinsky of Iovance Biotherapeutics subject to Rule 16b-3
Macroaxis News
few days ago at benzinga.com         
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635
benzinga news
over a week ago at news.google.com         
Disposition of 2812 shares by Igor Bilinsky of Iovance Biotherapeutics subject to Rule 16b-3
Google News at Macroaxis
over two weeks ago at fool.com         
Better Growth Biotech Buy Iovance Biotherapeutics vs CRISPR Therapeutics
fool News
over three weeks ago at zacks.com         
Iovance Biotherapeutics Down 6.9 percent Since Last Earnings Report Can It Rebound?
zacks News
over three weeks ago at fool.com         
2 Soaring Growth Stocks That Could Climb Another 47 percent to 73, According to Wall Street
fool News
over a month ago at finance.yahoo.com         
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635
Yahoo News
over a month ago at news.google.com         
Iovance Biotherapeutics Stock Price Up 4.8 percent - MarketBeat
Google News at Macroaxis
over a month ago at news.google.com         
Will Iovance Biotherapeutics Inc Outperform the Rest of the Stocks in the Healthcare Sector - Invest...
Google News at Macroaxis
over a month ago at news.google.com         
Piper Sandler lifts Iovance Biotherapeutics stock target to 19 By Investing.com - Investing.com
Google News at Macroaxis
over three months ago at news.google.com         
Form 485BPOS INSTITUTIONAL FIDUCIARY - StreetInsider.com
Google News at Macroaxis
18 hours ago at finance.yahoo.com         
Xaira Therapeutics Launches to Deliver Transformative Medicines by Advancing and Harnessing AI for D...
Yahoo News
2 days ago at finance.yahoo.com         
This CEO has battled billionaire activist Carl Icahn twice heres his advice to Disney CEO Bob Iger
Yahoo News
few days ago at finance.yahoo.com         
Can Illumina Keep the Earnings Surprise Streak Alive?
Yahoo News
few days ago at finance.yahoo.com         
Engineering a Cool Career in Biotech - and Volunteering Along the Way
Yahoo News
few days ago at businesswire.com         
Delve Bio presents study showing utility of metagenomic next generation sequencing in diagnosing neu...
businesswire News
few days ago at accesswire.com         
Evidence Supports Sequencing As First-Line Rare Disease Diagnostic
news
over a week ago at bnnbloomberg.ca         
Rubrik Is Seeking IPO of as Much as 713 Million
bloomberg News
over a week ago at economist.com         
Bitter medicine America hits Chinese biotechand its own drugmakers
Macroaxis News: economist.com
over a week ago at finance.yahoo.com         
UPDATE 1-EU approves Illuminas plan to divest cancer test maker Grail
Yahoo News
over a week ago at investing.com         
Illumina moves closer to GRAIL divestiture with EC nod
Investing News at Macroaxis
over six months ago at www.macroaxis.com         
Disposition of 110447 shares by Thomas Watkins of Horizon Pharma subject to Rule 16b-3
Macroaxis News
over six months ago at news.google.com         
Institutional owners may consider drastic measures as Vir Biotechnology, Inc.s recent US85m drop add...
Google News at Macroaxis
over six months ago at businesswire.com         
Horizon Therapeutics plc Rule 2.12 Announcement
businesswire News
over six months ago at benzinga.com         
Heres How Much 1000 Invested In Horizon Therapeutics 10 Years Ago Would Be Worth Today
benzinga news
over six months ago at news.google.com         
U.S. FTC allows Amgen to move forward with 27.8 bln Horizon deal - CNBC - Marketscreener.com
Google News at Macroaxis
over six months ago at thelincolnianonline.com         
Toronto Dominion Bank Buys 185,145 Shares of Horizon Therapeutics Public Limited
news
over six months ago at finance.yahoo.com         
Horizon Up as FTC Pauses Acquisition by Amgen Lawsuit
Yahoo News
over six months ago at finance.yahoo.com         
Horizon Therapeutics plc Ranks First in Overall Corporate Reputation by Rare Disease Patient Advocac...
Yahoo News
over six months ago at marketwatch.com         
George Soros has a big stake in this stock but its posted a roughly 9 percent loss this year. Are th...
marketwatch News
over six months ago at thelincolnianonline.com         
Horizon Therapeutics Public Issues Earnings Results
news
18 hours ago at finance.yahoo.com         
Incyte Earnings Expected to Grow Should You Buy?
Yahoo News
3 days ago at nypost.com         
Inside the world of a silent nun
news
few days ago at zacks.com         
Gilead Sciences Increases Despite Market Slip Heres What You Need to Know
zacks News
few days ago at zacks.com         
Analysts Estimate Gilead Sciences to Report a Decline in Earnings What to Look Out for
zacks News
few days ago at zacks.com         
Gilead Sciences Sees a More Significant Dip Than Broader Market Some Facts to Know
zacks News
few days ago at finance.yahoo.com         
GILEAD SCIENCES JOIN FORCES WITH WORLD HEPATITIS ALLIANCE AND EXPERTS TO AWARD US4 MILLION ALL4LIVER...
Yahoo News
six days ago at finance.yahoo.com         
Vittoria Biotherapeutics Announces Keith Westby as Chief Operating Officer
Yahoo News
six days ago at zacks.com         
Gilead Sciences, Inc. is Attracting Investor Attention Here is What You Should Know
zacks News
over a week ago at kalkinemedia.com         
GILEAD SCIENCES JOIN FORCES WITH WORLD HEPATITIS ALLIANCE AND EXPERTS TO AWARD US4 MILLION ALL4LIVER...
news
over a week ago at finance.yahoo.com         
Should You Invest in the VanEck Biotech ETF?
Yahoo News
few days ago at news.google.com         
Deciphera Pharmaceuticals, Inc. Sees Significant Increase in Short Interest - MarketBeat
Google News at Macroaxis
over a week ago at finance.yahoo.com         
Deciphera Pharmaceuticals to Present at the Stifel 2024 Virtual Targeted Oncology Forum
Yahoo News
over three weeks ago at www.macroaxis.com         
Disposition of 2403 shares by Daniel Flynn of Deciphera Pharmaceuticals at 21.2413 subject to Rule 1...
Macroaxis News
over a month ago at news.google.com         
Deciphera Pharmaceuticals Given New 16.00 Price Target at JPMorgan Chase Co. - MarketBeat
Google News at Macroaxis
over a month ago at zacks.com         
Why Is Biogen Inc. Up 2.6 percent Since Last Earnings Report?
zacks News
over a month ago at news.google.com         
Hsbc Holdings PLC Has 237000 Position in Deciphera Pharmaceuticals, Inc. - Defense World
Google News at Macroaxis
over a month ago at zacks.com         
Why Is Deciphera Pharmaceuticals, Inc. Up 20.8 percent Since Last Earnings Report?
zacks News
over a month ago at thelincolnianonline.com         
Q1 2024 EPS Estimates for Deciphera Pharmaceuticals, Inc. Decreased by Zacks Research
news
over a month ago at thelincolnianonline.com         
Analysts Issue Forecasts for Deciphera Pharmaceuticals, Inc.s FY2026 Earnings
news
over two months ago at www.macroaxis.com         
Disposition of 2267 shares by Daniel Martin of Deciphera Pharmaceuticals at 15.6176 subject to Rule ...
Macroaxis News
3 days ago at news.google.com         
Sumitomo Mitsui Trust Holdings Inc. Sells 5805 Shares of BioMarin Pharmaceutical Inc. - Defense Worl...
Google News at Macroaxis
few days ago at news.google.com         
BioMarin Pharmaceutical Expected to Beat Earnings Estimates Should You Buy - Yahoo Finance
Google News at Macroaxis
over a week ago at news.google.com         
Erin Burkhart Sells 2286 Shares of BioMarin Pharmaceutical Inc. Stock - Defense World
Google News at Macroaxis
over a week ago at gurufocus.com         
Disposition of 20000 shares by Bienaime Jean Jacques of Biomarin Pharmaceutical at 63.1 subject to R...
Gurufocus Stories at Macroaxis
over a week ago at finance.yahoo.com         
BioMarin to Host First Quarter 2024 Financial Results Conference Call and Webcast on Wednesday, Apri...
Yahoo News
over two weeks ago at news.google.com         
BioMarin Pharmaceutical Inc. Stake Decreased by Assenagon Asset Management S.A. - MarketBeat
Google News at Macroaxis
over two weeks ago at investing.com         
Biomarin exec sells over 2.1m in company stock
Investing News at Macroaxis
over three weeks ago at finance.yahoo.com         
Why Is Beam Therapeutics Down 22.1 percent Since Last Earnings Report?
Yahoo News
over three weeks ago at businesswire.com         
CORRECTING and REPLACING Jean-Jacques Bienaim Appointed Chairman of the Board at Owkin
businesswire News
over a month ago at news.google.com         
BioMarin Pharmaceutical Inc. Stock Position Cut by Baker Tilly Wealth Management LLC - Defense World
Google News at Macroaxis
a minute ago at kalkinemedia.com         
Japan gives priority review status to Alzheimers drug developed by Eisai, Biogen
news
3 days ago at finance.yahoo.com         
BioArctic and Eisai sign research evaluation agreement regarding BAN2802
Yahoo News
few days ago at forbes.com         
Pfizer On The New Lows List. Big Dividend Fails To Attract Buyers.
Usa forbes News
few days ago at finance.yahoo.com         
Alzheimers Therapeutics Market Size Expected to Surpass USD 8.18 Bn by 2032
Yahoo News
few days ago at finance.yahoo.com         
Blood Screening Market to Grow at CAGR of 11.6 percent through 2033 High Investment in Blood Transfu...
Yahoo News
few days ago at finance.yahoo.com         
Biogen Inc. Reports Next Week Wall Street Expects Earnings Growth
Yahoo News
six days ago at finance.yahoo.com         
QuantHealth Appoints Esteemed Pharmaceutical Executives to Inaugural Advisory Board
Yahoo News
over a week ago at statnews.com         
STAT Can investing in infectious disease pay off Vir Biotechnologys tightrope walk shows its a strug...
news
over a week ago at finance.yahoo.com         
EISAI TO PRESENT DATA ON ROBUST NEUROLOGY PORTFOLIO AT THE 76th AMERICAN ACADEMY OF NEUROLOGY ANNUAL...
Yahoo News
over a week ago at streetinsider.com         
INVESTOR CALLVirtualwares CEO to present Annual Report to shareholders
Street Insider News
few days ago at news.google.com         
Objective longshort Report - Stock Traders Daily
Google News at Macroaxis
over a week ago at news.google.com         
Raymond James Financial Services Advisors Inc. Trims Position in Ascendis Pharma AS - Defense World
Google News at Macroaxis
over a week ago at news.google.com         
Long Term Investment Analysis - Stock Traders Daily
Google News at Macroaxis
over two weeks ago at news.google.com         
Ascendis Pharma AS Given New 167.00 Price Target at JPMorgan Chase Co. - MarketBeat
Google News at Macroaxis
over three weeks ago at news.google.com         
1616 Shares in Ascendis Pharma AS Purchased by Legato Capital Management LLC - Defense World
Google News at Macroaxis
over a month ago at zacks.com         
Are Medical Stocks Lagging AdaptHealth This Year?
zacks News
over a month ago at news.google.com         
When the Price of Talks, People Listen - Stock Traders Daily
Google News at Macroaxis
over a month ago at benzinga.com         
Heres How Much 100 Invested In Ascendis Pharma 15 Years Ago Would Be Worth Today
benzinga news
over a month ago at thelincolnianonline.com         
Sei Investments Co. Reduces Position in Ascendis Pharma AS
news
over a month ago at finance.yahoo.com         
Is AdaptHealth Stock Outpacing Its Medical Peers This Year?
Yahoo News
a day ago at www.macroaxis.com         
Acquisition by Alstead Troy of tradable shares of Array TechnologiesInc subject to Rule 16b-3
Macroaxis News
over a week ago at zacks.com         
Will Array Technologies Beat Estimates Again in Its Next Earnings Report?
zacks News
over a week ago at www.macroaxis.com         
Acquisition by Travis Rose of 14645 shares of Array TechnologiesInc subject to Rule 16b-3
Macroaxis News
over two weeks ago at investorplace.com         
The 3 Most Undervalued Renewable Energy Stocks to Buy in April 2024
sbwire news
over three weeks ago at news.google.com         
Insider Trading
Google News at Macroaxis
over three weeks ago at finance.yahoo.com         
Why Array Technologies, Inc. Looks Like A Quality Company
Yahoo News
over a month ago at gurufocus.com         
Array Technologies Inc CEO Kevin Hostetler Sells 8,176 Shares
Gurufocus Stories at Macroaxis
over a month ago at investorplace.com         
Disposition of 8176 shares by Kevin Hostetler of Array TechnologiesInc at 12.3 subject to Rule 16b-3
sbwire news
over a month ago at investing.com         
Array Technologies shares get Sector Weight by KeyBanc, sees gradual recovery
Investing News at Macroaxis
over a month ago at finance.yahoo.com         
Array Technologies, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predicti...
Yahoo News
six days ago at benzinga.com         
argenx Data Highlight Evidence that VYVGART and VYVGART Hytrulo Drive Transformative Outcomes for Pa...
benzinga news
over three weeks ago at finance.yahoo.com         
Heres Why argenx SE Pulled Back 23 percent in Q4
Yahoo News
over three weeks ago at benzinga.com         
argenx Announces Annual General Meeting of Shareholders on May 7, 2024
benzinga news
over a month ago at seekingalpha.com         
Argenx stock gains after RocheChugai myasthenia gravis data
seekingalpha News
over a month ago at insidermonkey.com         
5 Biggest Biotechnology Companies in the World
insidermonkey News
over a month ago at thelincolnianonline.com         
47,735 Shares in argenx SE Acquired by Royal London Asset Management Ltd.
news
over a month ago at thelincolnianonline.com         
HC Wainwright Reaffirms Buy Rating for argenx
news
over a month ago at thelincolnianonline.com         
Schonfeld Strategic Advisors LLC Grows Position in argenx SE
news
over a month ago at finance.yahoo.com         
argenx SE Q4 2023 Earnings Call Transcript
Yahoo News
over a month ago at seekingalpha.com         
Argenx SE Q4 2023 Earnings Preview
seekingalpha News
18 hours ago at finance.yahoo.com         
Disposition of 2508 shares by Matthew Busch of Amgen at 235.97 subject to Rule 16b-3
Yahoo News
2 days ago at www.macroaxis.com         
Disposition of 2508 shares by Matthew Busch of Amgen at 235.97 subject to Rule 16b-3
Macroaxis News
few days ago at investing.com         
Disposition of 2508 shares by Matthew Busch of Amgen at 235.97 subject to Rule 16b-3
Investing News at Macroaxis
few days ago at finance.yahoo.com         
Disposition of 2508 shares by Matthew Busch of Amgen at 235.97 subject to Rule 16b-3
Yahoo News
few days ago at finance.yahoo.com         
Paycor Leverages Visiers AI Technology to Empower Businesses to Access Answers About Their Workforce
Yahoo News
few days ago at zacks.com         
Amgen Suffers a Larger Drop Than the General Market Key Insights
zacks News
six days ago at finance.yahoo.com         
Global Liver Cancer Drug Market Size To Worth USD 7.6 Billion By 2033 CAGR Of 10.90
Yahoo News
six days ago at finance.yahoo.com         
Disposition of 2508 shares by Matthew Busch of Amgen at 235.97 subject to Rule 16b-3
Yahoo News
over a week ago at aol.com         
Neumoras early-stage schizophrenia drug study put on hold
news
over a week ago at marketbeat.com         
Columbus Macro, LLC Top Holdings and 13F Report
Marketbeat News
18 hours ago at businesswire.com         
Samenvatting Incyte kondigt overname aan van Escient Pharmaceuticals en pijplijn van eersteklas oral...
businesswire News
six days ago at finance.yahoo.com         
Innovent Announces the Appointment of Dr. Nageatte Ibrahim as the Oncology Chief Medical Officer
Yahoo News
over a week ago at finance.yahoo.com         
The past three years for Incyte investors has not been profitable
Yahoo News
over a week ago at finance.yahoo.com         
Want Better Returns Dont Ignore These 2 Medical Stocks Set to Beat Earnings
Yahoo News
over a week ago at statnews.com         
Pfizers plot to win the RSV vaccine race
news
over two weeks ago at seekingalpha.com         
Jury sides with SEC in trial over insider trading charges against former pharma executive
seekingalpha News
over two weeks ago at finance.yahoo.com         
Acquisition by Paul Clancy of 403 shares of Incyte at 56.97 subject to Rule 16b-3
Yahoo News
over two weeks ago at seekingalpha.com         
Incyte, CMS collaborate for povorcitinib in Mainland China, Hong Kong, Macau, Taiwan, SEA
seekingalpha News
over three weeks ago at businesswire.com         
Incyte Reports Inducement Grant Under Nasdaq Listing Rule 5635
businesswire News
over three weeks ago at finance.yahoo.com         
Innovent Dosed First Participant in Phase 3 Clinical Study of IBI310 in Combination with Sintilimab ...
Yahoo News
over a year ago at finance.yahoo.com         
Orphan Drug Market Size Share to Surpass 3199.3 Billion by 2028 Vantage Market Research
Yahoo News
18 hours ago at businesswire.com         
Disposition of 4564 shares by Kimberly Manhard of Heron Therapeuti subject to Rule 16b-3
businesswire News
over a week ago at www.macroaxis.com         
Disposition of 42631 shares by Lisa Peraza of Heron Therapeuti subject to Rule 16b-3
Macroaxis News
over a week ago at statnews.com         
STAT Up and down the ladder The latest comings and goings
news
over two weeks ago at www.macroaxis.com         
Disposition of 62500 shares by Craig Collard of Heron Therapeuti subject to Rule 16b-3
Macroaxis News
over three weeks ago at news.google.com         
The past three years for Heron Therapeutics investors has not been profitable - Yahoo Movies UK
Google News at Macroaxis
over three weeks ago at news.google.com         
Does Heron Therapeutics Inc Have What it Takes to be in Your Portfolio Monday - InvestorsObserver
Google News at Macroaxis
over a month ago at cleveland.com         
Predicting the Guardians opening day roster with one week left in training camp
news
over a month ago at simplywall.st         
Heres What Analysts Are Forecasting For Heron Therapeutics, Inc. After Its Full-Year Results
Simply Wall St News at Macroaxis
over a month ago at investing.com         
Needham raises Heron Therapeutics stock PT to 5 on strong 2023 finish
Investing News at Macroaxis
over a month ago at seekingalpha.com         
Solid Biosciences, Cue Biopharma, Annexon among healthcare movers
seekingalpha News
Far too much social signal, news, headlines, and media speculation about Franklin Biotechnology that are available to investors today. That information is available publicly through Franklin media outlets and privately through word of mouth or via Franklin internal channels. However, regardless of the origin, that massive amount of Franklin data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Franklin Biotechnology news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Franklin Biotechnology relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Franklin Biotechnology's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Franklin Biotechnology alpha.

Franklin Biotechnology Minimum Initial Investment

Based on the recorded statements, Franklin Biotechnology Discovery has a Minimum Initial Investment of 100 K. This is 65.56% higher than that of the Franklin Templeton Investments family and significantly higher than that of the Health category. The minimum initial investment for all United States funds is notably lower than that of the firm.
Fund managers put minimum investment restrictions on fund investments in order to allow the fund to function properly. Minimum restrictions allow fund managers to regulate cash flows of the fund, while guarding it against random trades that may negatively affect fund strategy.
Check out Franklin Biotechnology Hype Analysis, Franklin Biotechnology Correlation and Franklin Biotechnology Performance.
Note that the Franklin Biotechnology information on this page should be used as a complementary analysis to other Franklin Biotechnology's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Please note, there is a significant difference between Franklin Biotechnology's value and its price as these two are different measures arrived at by different means. Investors typically determine if Franklin Biotechnology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Franklin Biotechnology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.